A detailed history of Raymond James & Associates transactions in Inari Medical, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 14,771 shares of NARI stock, worth $733,527. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,771
Previous 6,657 121.89%
Holding current value
$733,527
Previous $320,000 90.31%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$40.68 - $58.62 $330,077 - $475,642
8,114 Added 121.89%
14,771 $609,000
Q2 2024

Jul 19, 2024

BUY
$37.11 - $50.69 $3,562 - $4,866
96 Added 1.46%
6,657 $320,000
Q1 2024

Apr 22, 2024

BUY
$40.65 - $65.76 $131,218 - $212,273
3,228 Added 96.85%
6,561 $314,000
Q4 2023

Jan 16, 2024

BUY
$48.3 - $68.06 $160,983 - $226,843
3,333 New
3,333 $216,000
Q4 2022

Feb 08, 2023

SELL
$61.23 - $83.62 $35,697 - $48,750
-583 Reduced 13.45%
3,752 $238,000
Q3 2022

Oct 25, 2022

SELL
$65.58 - $84.69 $5,443 - $7,029
-83 Reduced 1.88%
4,335 $315,000
Q2 2022

Aug 12, 2022

BUY
$52.13 - $93.81 $1,668 - $3,001
32 Added 0.73%
4,418 $300,000
Q1 2022

May 11, 2022

BUY
$64.92 - $99.47 $4,933 - $7,559
76 Added 1.76%
4,386 $398,000
Q4 2021

Feb 08, 2022

SELL
$76.51 - $93.96 $302,673 - $371,705
-3,956 Reduced 47.86%
4,310 $393,000
Q3 2021

Nov 02, 2021

SELL
$71.29 - $95.99 $716,892 - $965,275
-10,056 Reduced 54.88%
8,266 $670,000
Q2 2021

Aug 11, 2021

SELL
$79.62 - $114.85 $136,548 - $196,967
-1,715 Reduced 8.56%
18,322 $1.71 Million
Q1 2021

May 14, 2021

BUY
$77.91 - $125.92 $902,743 - $1.46 Million
11,587 Added 137.12%
20,037 $2.14 Million
Q4 2020

Feb 12, 2021

BUY
$60.0 - $87.29 $507,000 - $737,600
8,450 New
8,450 $738,000

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $2.65B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.